Biofrontera AG announces that the Supervisory Board decided in its meeting on August 19, 2022, to extend the appointment of Mr. Paul Böckmann as member of the Management Board until September 30, 2022. Mr. Paul Böckmann will continue to be available to the company in an advisory capacity until the end of October.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.328 EUR | -1.80% | +0.61% | -18.20% |
Mar. 11 | Biofrontera Files Prospectus for Potential Secondary Stock Offerings | MT |
Mar. 05 | Medicus Pharma Names COO | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.20% | 22.42M | |
+24.65% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.28% | 233B | |
+5.62% | 201B | |
-10.22% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- B8F Stock
- News Biofrontera AG
- Biofrontera AG Extends Appointment of Management Board Member Paul Böckmann